TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34864959 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34865186 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study 34865186 — Predictive Biomarker (PRD): GMCL2 mRNA
Genes: GMCL2; GCL; GMCL1L; GMCL1P1
Study 34865186 — Predictive Biomarker (PRD): PHLDA2 mRNA
Genes: PHLDA2; BWR1C; HLDA2; IPL; TSSC3
Study 34865212 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34867148 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34867148 — Safety Biomarker (SAF): BDNF
Study 34868003 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34868003 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34868050 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34868687 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34869442 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34870327 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34870789 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study 34870878 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34871089 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34871104 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34871104 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34871190 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study 34871190 — Predictive Biomarker (PRD): ALPP mRNA
Genes: ALPP; PLAP
Study 34871241 — Monitoring Biomarker (MOI): Procalcitonin
Study 34871308 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34871341 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34871371 — Safety Biomarker (SAF): Interleukin 12
Study 34871570 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 34871572 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34872106 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34872515 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 34872617 — Surrogate Endpoint (SUR): Blood pressure
Study 34873345 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 34873347 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 34873795 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 34873795 — Predictive Biomarker (PRD): SCARA3 mRNA
Genes: SCARA3; CSR
Study 34874345 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 34875023 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34875023 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34875107 — Predictive Biomarker (PRD): Microsatellite instability
Study 34876396 — Surrogate Endpoint (SUR): Blood pressure
Study 34876408 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 34876409 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34876409 — Predictive Biomarker (PRD): Microsatellite instability
Study 34878437 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34878624 — Predictive Biomarker (PRD): Hormone receptor
Study 34878898 — Surrogate Endpoint (SUR): Blood pressure
Study 34879833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34879833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34880117 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34882589 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34884196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34887348 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study 34887574 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 34887574 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34888099 — Surrogate Endpoint (SUR): Blood pressure
Study 34889102 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34889102 — Surrogate Endpoint (SUR): Blood pressure
Study 34889102 — Surrogate Endpoint (SUR): Serum creatinine
Study 34889102 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 34889102 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34889108 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 34889108 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 34889232 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 34889407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34890832 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34890832 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34890832 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study 34890832 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 34890832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 34891223 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34893603 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34893603 — Predictive Biomarker (PRD): TNFRSF19 mRNA
Genes: TNFRSF19; TAJ; TROY; UNQ1888/PRO4333
Study 34893771 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 34893775 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34893945 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study 34894235 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34894328 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34894328 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 34894681 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 34895264 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 34895290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34895487 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34895487 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34896356 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34900737 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34901220 — Surrogate Endpoint (SUR): Blood pressure
Study 34901797 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34901915 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34902012 — Surrogate Endpoint (SUR): Blood pressure
Study 34902047 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 34902623 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 34902623 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 34902760 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34902818 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34903218 — Surrogate Endpoint (SUR): Bone mineral density
Study 34903452 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34903842 — Predictive Biomarker (PRD): IL1RAP mRNA
Genes: IL1RAP; C3orf13; IL1R3
Study 34903842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34903842 — Safety Biomarker (SAF): Interleukin 1
Study 34904813 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study 34904813 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 34906487 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study 34907192 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 34907980 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34909518 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34909566 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 34909566 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34910278 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 34910295 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34910821 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 34911359 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 34911359 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34911359 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34911463 — Surrogate Endpoint (SUR): Blood pressure
Study 34911479 — Predictive Biomarker (PRD): CPOX mRNA
Genes: CPOX; CPO; CPX
Study 34911721 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34911956 — Predictive Biomarker (PRD): SOX2 mRNA
Genes: SOX2
Study 34911956 — Predictive Biomarker (PRD): POU5F1 mRNA
Genes: POU5F1; OCT3; OCT4; OTF3
Study 34911956 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 34913584 — Predictive Biomarker (PRD): CLN3 mRNA
Genes: CLN3; BTS
Study 34913611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34914545 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34914826 — Predictive Biomarker (PRD): Hepatitis A virus cellular receptor 2
Genes: HAVCR2; TIM3; TIMD3
Study 34915264 — Surrogate Endpoint (SUR): Blood pressure
Study 34915574 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 34916324 — Predictive Biomarker (PRD): SLC4A7 mRNA
Genes: SLC4A7; BT; NBC2; NBC2B; NBC3; NBCn1; SBC2; SLC4A6
Study 34916324 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34916327 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study 34916627 — Surrogate Endpoint (SUR): Blood pressure
Study 34917079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34917174 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34917174 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34918637 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 34918855 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34919824 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34920917 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34920917 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34921021 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34921052 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34921084 — Surrogate Endpoint (SUR): Bone mineral density
Study 34921238 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34921324 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 34921669 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study 34921845 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study 34922608 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 34922608 — Surrogate Endpoint (SUR): Blood pressure
Study 34923853 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34923853 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study 34925553 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34926296 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 34928481 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34928481 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34928481 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 34928481 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34928709 — Predictive Biomarker (PRD): FATE1 mRNA
Genes: FATE1; FATE
Study 34929010 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 34929034 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34930140 — Monitoring Biomarker (MOI): HBV DNA
Study 34930165 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34930165 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 34930428 — Surrogate Endpoint (SUR): Blood pressure
Study 34930487 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 34930717 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 34931603 — Surrogate Endpoint (SUR): Blood pressure
Study 34932284 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 34932394 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34932793 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34932828 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34932828 — Surrogate Endpoint (SUR): Serum creatinine
Study 34932828 — Surrogate Endpoint (SUR): Blood pressure
Study 34932984 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 34932984 — Predictive Biomarker (PRD): GCG mRNA
Genes: GCG
Study 34933330 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 34933330 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 34933824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34933964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34934034 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study 34934447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34934447 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34934801 — Predictive Biomarker (PRD): DPYSL3 mRNA
Genes: DPYSL3; CRMP4; DRP3; ULIP; ULIP1
Study 34934978 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34934987 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34934987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34935127 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study 34935409 — Surrogate Endpoint (SUR): Blood pressure
Study 34935483 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34935913 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 34936689 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 34936849 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 34937583 — Surrogate Endpoint (SUR): Blood pressure
Study 34937709 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34937722 — Surrogate Endpoint (SUR): Blood pressure
Study 34937724 — Surrogate Endpoint (SUR): Serum potassium
Study 34938664 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34939013 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 34939972 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34941929 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34941996 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34941996 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34942516 — Predictive Biomarker (PRD): SIGLEC1 mRNA
Genes: SIGLEC1; SN
Study 34949130 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34949190 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 34950880 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34950880 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34950913 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 34950913 — Surrogate Endpoint (SUR): Blood pressure
Study 34951522 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 34951522 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34951522 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 34951993 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34952415 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 34952679 — Surrogate Endpoint (SUR): Pathological complete response
Study 34952953 — Surrogate Endpoint (SUR): Blood pressure
Study 34952962 — Predictive Biomarker (PRD): MMP12 mRNA
Genes: MMP12; HME
Study 34953442 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34953442 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34953442 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34953442 — Predictive Biomarker (PRD): Hormone receptor
Study 34953624 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34953816 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34953862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34954052 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 34954325 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34954696 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 34955406 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 34955891 — Predictive Biomarker (PRD): RGS16 mRNA
Genes: RGS16; RGSR
Study 34955891 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 34957480 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 34958346 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 34958928 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34959133 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 34959133 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 34959133 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 34959133 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34961476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34961547 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 34961902 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 34962628 — Surrogate Endpoint (SUR): Blood pressure
Study 34963563 — Surrogate Endpoint (SUR): Pathological complete response
Study 34965620 — Surrogate Endpoint (SUR): Probing pocket depth
Study 34965951 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34966667 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34967916 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34968756 — Predictive Biomarker (PRD): GAL3ST1 mRNA
Genes: GAL3ST1; CST
Study 34968756 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34969397 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34969665 — Predictive Biomarker (PRD): CYP1A1 mRNA
Genes: CYP1A1
Study 34969665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34970476 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34970774 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34970774 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34971971 — Predictive Biomarker (PRD): FDPS mRNA
Genes: FDPS; FPS; KIAA1293
Study 34971971 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 34972202 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34972260 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34972769 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34975713 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34976290 — Predictive Biomarker (PRD): CAMP mRNA
Genes: CAMP; CAP18; FALL39; HSD26
Study 34976630 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 34976830 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34977519 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 34977972 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34978654 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 34978654 — Surrogate Endpoint (SUR): Blood pressure
Study 34979020 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34979928 — Surrogate Endpoint (SUR): Blood pressure
Study 34980038 — Monitoring Biomarker (MOI): Cell-free HPV DNA
Study 34980502 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study 34980541 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study 34980577 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 34980577 — Predictive Biomarker (PRD): Microsatellite instability
Study 34980597 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34980633 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34980909 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34981077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1